Molecule Information
General Information of the Molecule (ID: Mol00812)
Name |
Bacitracin transport permease protein BCRB (BCRB)
,Bacillus licheniformis
|
||||
---|---|---|---|---|---|
Molecule Type |
Protein
|
||||
Gene Name |
bcrB
|
||||
Sequence |
MAKKAKYPDVPIRFSETFSDTNLYIVLLIGVPLYGVITSYLFNREYAESTLKNLLTIPVS
RISLIVSKLVLLLIWIMMLTLIAWVLTLLFGLIGQFEGLSSAVLIEGFKQFMIGGALLFF LVSPIIFVTLLFKNYVPTIIFTIIISMVSIMVYGTEYSALFPWSAVWVIASGTFFPEYPP EYSFISVAATTVLGLAATIVYFKKIDIH Click to Show/Hide
|
||||
Function |
Part of the binding-protein-dependent transport system for bacitracin that confer resistance to this antibiotic; probably responsible for the translocation of the substrate across the membrane.
Click to Show/Hide
|
||||
Uniprot ID | |||||
Click to Show/Hide the Complete Species Lineage | |||||
Type(s) of Resistant Mechanism of This Molecule
IDUE: Irregularity in Drug Uptake and Drug Efflux
Drug Resistance Data Categorized by Drug
Approved Drug(s)
3 drug(s) in total
Bacitracin A
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Bacillus licheniformis infection | [1] | |||
Resistant Disease | Bacillus licheniformis infection [ICD-11: 1C4Y.2] | |||
Resistant Drug | Bacitracin A | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | How could the proposed export function of the Bcr permease account for the bacitracin resistance The transported molecule could be either the substance inactivating the antibiotic or the antibiotic alone. As already observed. some of the metabolites could inhibit the bactericidal activity of bacitracin at very low concentrations. However, in S. subfitis and Escherichia coli strains carrying cloned bcr genes, no substances that could suppress bacitracin activity were detected. It seems that the bacitracin is indeed the target of the Bcr ABC transporter. | |||
Disease Class: Escherichia coli infection | [1] | |||
Resistant Disease | Escherichia coli infection [ICD-11: 1A03.0] | |||
Resistant Drug | Bacitracin A | |||
Molecule Alteration | Expression | Acquired |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The nucleotide sequence of the Bacillus licheniformis bacitracin-resistance locus was determined. The presence of three open reading frames, bcrA, bcrB and bcrC, was revealed. The BcrA protein shares a high degree of homology with the hydrophilic ATP-binding components of the ABC family of transport proteins. The bcrB and bcrC genes were found to encode hydrophobic proteins, which may function as membrane components of the permease. Apart from Bacillus subtilis, these genes also confer resistance upon the Gram-negative Escherichia coli. | |||
Disease Class: Bacillus subtilis infection | [1] | |||
Resistant Disease | Bacillus subtilis infection [ICD-11: 1G40.1] | |||
Resistant Drug | Bacitracin A | |||
Molecule Alteration | Expression | Acquired |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The nucleotide sequence of the Bacillus licheniformis bacitracin-resistance locus was determined. The presence of three open reading frames, bcrA, bcrB and bcrC, was revealed. The BcrA protein shares a high degree of homology with the hydrophilic ATP-binding components of the ABC family of transport proteins. The bcrB and bcrC genes were found to encode hydrophobic proteins, which may function as membrane components of the permease. Apart from Bacillus subtilis, these genes also confer resistance upon the Gram-negative Escherichia coli. |
Bacitracin F
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Bacillus licheniformis infection | [1] | |||
Resistant Disease | Bacillus licheniformis infection [ICD-11: 1C4Y.2] | |||
Resistant Drug | Bacitracin F | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | How could the proposed export function of the Bcr permease account for the bacitracin resistance The transported molecule could be either the substance inactivating the antibiotic or the antibiotic alone. As already observed. some of the metabolites could inhibit the bactericidal activity of bacitracin at very low concentrations. However, in S. subfitis and Escherichia coli strains carrying cloned bcr genes, no substances that could suppress bacitracin activity were detected. It seems that the bacitracin is indeed the target of the Bcr ABC transporter. | |||
Disease Class: Escherichia coli infection | [1] | |||
Resistant Disease | Escherichia coli infection [ICD-11: 1A03.0] | |||
Resistant Drug | Bacitracin F | |||
Molecule Alteration | Expression | Acquired |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The nucleotide sequence of the Bacillus licheniformis bacitracin-resistance locus was determined. The presence of three open reading frames, bcrA, bcrB and bcrC, was revealed. The BcrA protein shares a high degree of homology with the hydrophilic ATP-binding components of the ABC family of transport proteins. The bcrB and bcrC genes were found to encode hydrophobic proteins, which may function as membrane components of the permease. Apart from Bacillus subtilis, these genes also confer resistance upon the Gram-negative Escherichia coli. | |||
Disease Class: Bacillus subtilis infection | [1] | |||
Resistant Disease | Bacillus subtilis infection [ICD-11: 1G40.1] | |||
Resistant Drug | Bacitracin F | |||
Molecule Alteration | Expression | Acquired |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The nucleotide sequence of the Bacillus licheniformis bacitracin-resistance locus was determined. The presence of three open reading frames, bcrA, bcrB and bcrC, was revealed. The BcrA protein shares a high degree of homology with the hydrophilic ATP-binding components of the ABC family of transport proteins. The bcrB and bcrC genes were found to encode hydrophobic proteins, which may function as membrane components of the permease. Apart from Bacillus subtilis, these genes also confer resistance upon the Gram-negative Escherichia coli. |
Bacitracin methylene disalicylate
Drug Resistance Data Categorized by Their Corresponding Mechanisms | ||||
Irregularity in Drug Uptake and Drug Efflux (IDUE) | ||||
Disease Class: Bacillus licheniformis infection | [1] | |||
Resistant Disease | Bacillus licheniformis infection [ICD-11: 1C4Y.2] | |||
Resistant Drug | Bacitracin methylene disalicylate | |||
Molecule Alteration | Expression | Inherence |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | How could the proposed export function of the Bcr permease account for the bacitracin resistance The transported molecule could be either the substance inactivating the antibiotic or the antibiotic alone. As already observed. some of the metabolites could inhibit the bactericidal activity of bacitracin at very low concentrations. However, in S. subfitis and Escherichia coli strains carrying cloned bcr genes, no substances that could suppress bacitracin activity were detected. It seems that the bacitracin is indeed the target of the Bcr ABC transporter. | |||
Disease Class: Escherichia coli infection | [1] | |||
Resistant Disease | Escherichia coli infection [ICD-11: 1A03.0] | |||
Resistant Drug | Bacitracin methylene disalicylate | |||
Molecule Alteration | Expression | Acquired |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The nucleotide sequence of the Bacillus licheniformis bacitracin-resistance locus was determined. The presence of three open reading frames, bcrA, bcrB and bcrC, was revealed. The BcrA protein shares a high degree of homology with the hydrophilic ATP-binding components of the ABC family of transport proteins. The bcrB and bcrC genes were found to encode hydrophobic proteins, which may function as membrane components of the permease. Apart from Bacillus subtilis, these genes also confer resistance upon the Gram-negative Escherichia coli. | |||
Disease Class: Bacillus subtilis infection | [1] | |||
Resistant Disease | Bacillus subtilis infection [ICD-11: 1G40.1] | |||
Resistant Drug | Bacitracin methylene disalicylate | |||
Molecule Alteration | Expression | Acquired |
||
Experimental Note | Discovered Using In-vivo Testing Model | |||
In Vitro Model | Escherichia coli strain HB101 | 634468 | ||
Escherichia coli strain DH5alpha | 668369 | |||
Bacillus subtilis strain 1A685 | 1423 | |||
Bacillus subtilis strain vectors pHV143 | 1423 | |||
Bacillus ticheniformis strain FD | 1402 | |||
Experiment for Molecule Alteration |
Dideoxynucleotide chain-termination method assay | |||
Experiment for Drug Resistance |
MIC assay | |||
Mechanism Description | The nucleotide sequence of the Bacillus licheniformis bacitracin-resistance locus was determined. The presence of three open reading frames, bcrA, bcrB and bcrC, was revealed. The BcrA protein shares a high degree of homology with the hydrophilic ATP-binding components of the ABC family of transport proteins. The bcrB and bcrC genes were found to encode hydrophobic proteins, which may function as membrane components of the permease. Apart from Bacillus subtilis, these genes also confer resistance upon the Gram-negative Escherichia coli. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.